Cargando…

Randomized feasibility study of S-1 for adjuvant chemotherapy in completely resected Stage IA non–small-cell lung cancer: results of the Setouchi Lung Cancer Group Study 0701

OBJECTIVE: The aim of this multicenter study was to determine the appropriate administration schedule for S-1, an oral fluoropyrimidine, for adjuvant chemotherapy in patients with completely resected pathological-Stage IA (tumor diameter, 2–3 cm) non–small-cell lung cancer. METHODS: Patients were ra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Soh, Junichi, Okumura, Norihito, Nakata, Masao, Nakamura, Hiroshige, Fukuda, Minoru, Kataoka, Masafumi, Kajiwara, Shinsuke, Sano, Yoshifumi, Aoe, Motoi, Kataoka, Kazuhiko, Hotta, Katsuyuki, Matsuo, Keitaro, Toyooka, Shinichi, Date, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5025397/ https://www.ncbi.nlm.nih.gov/pubmed/27207886 http://dx.doi.org/10.1093/jjco/hyw062

Ejemplares similares

Randomized phase II study of daily and alternate-day administration of S-1 for adjuvant chemotherapy in completely-resected stage I non-small cell lung cancer: results of the Setouchi Lung Cancer Group Study 1301
por: Okumura, Norihito, et al.
Publicado: (2021)

Randomized phase II study of daily versus alternate-day administrations of S-1 for the elderly patients with completely resected pathological stage IA (tumor diameter > 2 cm)—IIIA of non-small cell lung cancer: Setouchi Lung Cancer Group Study 1201
por: Yamamoto, Hiromasa, et al.
Publicado: (2023)

Review of Setouchi International Art Festival/Setouchi Triennale 2016
por: Tanaka, Kathryn M.
Publicado: (2016)

Anti-tumor effect of bisphosphonate (YM529) on non-small cell lung cancer cell lines
por: Koshimune, Ryuichiro, et al.
Publicado: (2007)

Induction Chemoradiotherapy Followed by Surgical Resection for Clinical T3 or T4 Locally Advanced Non–Small Cell Lung Cancer
por: Shien, Kazuhiko, et al.
Publicado: (2012)

Hypofractionated carbon‐ion radiotherapy for stage I peripheral nonsmall cell lung cancer (GUNMA0701): Prospective phase II study
por: Saitoh, Jun‐ichi, et al.
Publicado: (2019)

Is Surgery after Chemoradiotherapy Feasible in Lung Cancer Patients with Superior Vena Cava Invasion?
por: Sato, Hiroki, et al.
Publicado: (2018)

Circum‐Setouchi conference: Transboundary support for residents in small‐scale programs
por: Mizumoto, Junki
Publicado: (2020)

Novel Germline Mutation in the Transmembrane Domain of HER2 in Familial Lung Adenocarcinomas
por: Yamamoto, Hiromasa, et al.
Publicado: (2013)

The relationship between aberrant methylation and survival in non-small-cell lung cancers
por: Toyooka, S, et al.
Publicado: (2004)

EGFR Mutation is a Prognostic Factor in Lung Cancer Patients with Pleural Dissemination Detected During or After Surgery
por: Fujiwara, Toshiya, et al.
Publicado: (2023)

Current status of surgery for clinical stage IA lung cancer in Japan: analysis of the national clinical database
por: Ikeda, Norihiko, et al.
Publicado: (2020)

A randomized phase III trial of oral S-1 plus cisplatin versus docetaxel plus cisplatin in Japanese patients with advanced non-small-cell lung cancer: TCOG0701 CATS trial
por: Kubota, K., et al.
Publicado: (2015)

Crizotinib for recurring non‐small‐cell lung cancer with EML4‐ALK fusion genes previously treated with alectinib: A phase II trial
por: Harada, Daijiro, et al.
Publicado: (2021)

Metastatic squamous cell carcinoma of the lung mimicking multiple bone abscesses
por: Haruta, Yuki, et al.
Publicado: (2017)

OA07.01. A naturopathic approach to the prevention of cardiovascular disease: a cost effectiveness analysis of a randomized multi-worksite trial
por: Herman, P, et al.
Publicado: (2012)

Anti-Cancer Effects of REIC/Dkk-3-encoding Adenoviral Vector for the Treatment of Non-small Cell Lung Cancer
por: Shien, Kazuhiko, et al.
Publicado: (2014)

Preoperative induction chemotherapy with cisplatin and irinotecan for pathological N(2) non-small cell lung cancer
por: Date, H, et al.
Publicado: (2002)

Spread through air spaces affects survival and recurrence of patients with clinical stage IA non-small cell lung cancer after wedge resection
por: Shiono, Satoshi, et al.
Publicado: (2020)

Antimalarial Iron Chelator, FBS0701, Shows Asexual and Gametocyte Plasmodium falciparum Activity and Single Oral Dose Cure in a Murine Malaria Model
por: Ferrer, Patricia, et al.
Publicado: (2012)

Gemtuzumab ozogamicin for de novo acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trial
por: Lambert, Juliette, et al.
Publicado: (2019)

A defect of amphiregulin release predicted longer survival independently of YAP expression in patients with pleural mesothelioma in the IFCT‐0701 MAPS phase 3 trial
por: Maille, Elodie, et al.
Publicado: (2022)

Immunohistochemical detection of pulmonary cytochrome P450IA and metabolic activities associated with P450IA1 and P450IA2 isozymes in lung cancer patients.
por: Anttila, S, et al.
Publicado: (1992)

Molecular profiling identifies prognostic markers of stage IA lung adenocarcinoma
por: Zhang, Jie, et al.
Publicado: (2017)

Active Surveillance for Medically Inoperable Stage IA Lung Cancer in the Elderly
por: No, Hyunsoo J, et al.
Publicado: (2018)

Role of breath-hold lung PET in stage IA pulmonary adenocarcinoma
por: Cheng, Zhaoping, et al.
Publicado: (2023)

Prognostic factors for lung transplant recipients focusing on age and gender: the Japanese lung transplantation report 2022
por: Oishi, Hisashi, et al.
Publicado: (2023)

Dose-volume parameters predict radiation pneumonitis after induction chemoradiotherapy followed by surgery for non-small cell lung cancer: a retrospective analysis
por: Katsui, Kuniaki, et al.
Publicado: (2019)

Selection of Pathological N0 (pN0) in Clinical IA (cIA) Lung Adenocarcinoma by Imaging Findings of the Main Tumor
por: Kanamoto, Yasuyuki, et al.
Publicado: (2020)

MST1/Hippo promoter gene methylation predicts poor survival in patients with malignant pleural mesothelioma in the IFCT-GFPC-0701 MAPS Phase 3 trial
por: Maille, Elodie, et al.
Publicado: (2019)

A putative merR family transcription factor Slr0701 regulates mercury inducible expression of MerA in the cyanobacterium Synechocystis sp. PCC6803
por: Singh, Deepak Kumar, et al.
Publicado: (2019)

Intrapulmonary lymph node metastasis is common in clinically staged IA adenocarcinoma of the lung
por: Zhang, DengGuo, et al.
Publicado: (2018)

Segmentectomy or Wedge Resection in Stage IA Lung Squamous Cell Carcinoma and Adenocarcinoma?
por: Li, Guoshu, et al.
Publicado: (2021)

Prognosis of segmentectomy in the treatment of stage IA non-small cell lung cancer
por: Bai, Wenliang, et al.
Publicado: (2021)

Genomic profile and immune microenvironment in patients with relapsed stage IA lung adenocarcinoma
por: Yang, Lu, et al.
Publicado: (2020)

Prognostic Radiological Tools for Clinical Stage IA Pure Solid Lung Cancer
por: Nakada, Takeo, et al.
Publicado: (2021)

Prognostic impact of noninvasive areas in resected pathological stage IA lung adenocarcinoma
por: Kinoshita, Fumihiko, et al.
Publicado: (2023)

Combined effect of cabozantinib and gefitinib in crizotinib‐resistant lung tumors harboring ROS1 fusions
por: Kato, Yuka, et al.
Publicado: (2018)

Clinical impact of gene mutations and lesions detected by SNP-array karyotyping in acute myeloid leukemia patients in the context of gemtuzumab ozogamicin treatment: Results of the ALFA-0701 trial
por: Renneville, Aline, et al.
Publicado: (2014)

Prognostic Nomograms Based on Ground Glass Opacity and Subtype of Lung Adenocarcinoma for Patients with Pathological Stage IA Lung Adenocarcinoma
por: Zhai, Wenyu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q1mp8dro0hurmgh8lk9aqvvaum